Sepsis Clinical Trial
— DIAGNOSEDOfficial title:
Comparison of the Performance Indicators (Sensitivity and Specificity) of qSOFA, SIRS, NEWS, and RETTS Scores, for Diagnosis of the Infected Patient at the Emergency Department Triage
Septic pathology is an extremely frequent reason for consultation in our emergency services,
with an annual incidence of severe forms between 50 to 95 cases per 100,000 inhabitants and a
constant increase estimated at 9% per year. Diagnosing these patients early and precisely is
a major challenge for the clinician, as this diagnosis will lead to more or less aggressive
medical management.
The criteria of S.I.R.S, used to define and to sort patients in sepsis according to the old
definition, were completely abandoned in the last recommendations for lack of specificity but
also of sensitivity. The latest recommendations suggest using another score, the "Quick
Sepsis Related Organ Failure Assesment (qSOFA) score", in order to early detect septic
patients at risk of poor progress. However, the recent literature highlights a very low
sensitivity of the qSOFA score for the screening of septic patients, ranging from 30 to 60%
according to the studies. In addition to qSOFA, other scores are described in the literature
with apparently higher sensitivity, and thus seem more suitable for our daily practice. Among
them is the NEWS score or the RETTS score.
Each of these scores is again based upon the values of vital signs recorded as soon as the
patient arrives in the emergency department. To date, very few studies have been interested,
in a prospective way, in the sensitivity and the specificity of these different scores to
diagnose the "infected" patients in the emergency departments.
Therefore a non-interventional, prospective, multicenter cohort study is carried out here, in
order to be able to compare, on the same cohort of patients admitted into emergency services,
the diagnostic performance of these different scores with respect to the presence or absence
of an infection.
The aim of this study is to define the best clinical score to use in emergency medicine to
quickly diagnose the infected patients, and offer them the best medical care.
Status | Completed |
Enrollment | 759 |
Est. completion date | September 1, 2018 |
Est. primary completion date | April 13, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patient of 18 years old or more - Patients consulting in the emergency department - Verbal agrement to participate Exclusion Criteria: - Patients consulting for an isolated traumatologic reason - Patients under legal protection |
Country | Name | City | State |
---|---|---|---|
France | Centre Hospitalier d'Antibes | Antibes | Alpes Maritimes |
France | Centre Hospitalier de Grasse | Grasse | Alpes Maritimes |
France | Hôpital de la Timone | Marseille | Bouches Du Rhône |
France | Hôpital Nord | Marseille | Bouches Du Rhône |
France | Centre Hospitalier Universitaire de Nice | Nice | Alpes Maritimes |
France | Hôpital Saint Anne | Toulon | Var |
France | Hôpital Sainte Musse | Toulon | Var |
Lead Sponsor | Collaborator |
---|---|
Association pour la Formation l'Enseignement et la Recherche du Service de l'Accueil des Urgences | Collège de Médecine d’Urgence de la Région PACA (COPACAMU) |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Initial vital signs upon arrival at ED triage to evaluate the qSOFA score | Respiratory rate (movements per minute) Systolic blood pressure (Hg mm) Glasgow coma score (number from 0 to 15) will be assessed to evaluate the qSOFA score (number from 0 to 3) |
Timepoint 0 (ED triage) | |
Primary | Initial vital signs upon arrival at ED triage to evaluate the NEWS score | Respiratory rate (movements per minute) Pulsed SpO2 (%) with oxygen therapy (if applicable) and without oxygen therapy Oxygen therapy (yes ou no) Tympanic temperature (°C) Systolic blood pressure (Hg mm) Heart rate (beats per minute) Glasgow coma score (number from 0 to 15) will be assessed to evaluate the NEWS score (number from 0 to 20) |
Timepoint 0 (ED triage) | |
Primary | Initial vital signs upon arrival at ED triage to evaluate the RETTS score | Blocked airway or stridor (yes or no) Respiratory rate (movements per minute) Pulsed SpO2 (%) without oxygen therapy Heart rate (beats per minute) Level of conciousness (alert, accute disorientation, somnolence, Glasgow<9) Tympanic temperature (°C) will be assessed to evaluate the RETTS score (4 classes from "green" to "red") |
Timepoint 0 (ED triage) | |
Primary | Initial vital signs upon arrival at ED triage and blood count to evaluate the SIRS score | Tympanic temperature (°C) Heart rate (beats per minute) Respiratory rate (movements per minute) Leucocytemia (cells per mm³) will be assessed to evaluate the SIRS score (number from 0 to 4) |
Timepoint 0 (ED triage) and timepoint of blood sampling upon medical examination (average of 30 minutes after Timepoint 0) | |
Primary | Antibiotic therapy instauration by the physician either during the emergency care managment or when leaving the emergency department (antibiotic therapy mentionned in the exit prescrition) | The prescription of an antibiotic therapy will define the presence of an infection | from patient arrival in the ED, to his leaving (from 1 hour to 24 hours) | |
Secondary | Presence of a SOFA score value of 2 or greater | The occurence of a SOFA score value of 2 or greater will define the presence of sepsis according to the last recommandations. Vital signs to be recorded for the SOFA score evaluation: Thrombocytemia (10^9/L) Bilirubinemia (µmol/l) Creatininemia (µmol/l) Glasgow coma score Average blood pressure (Hg mm) Cathecholamine usage Pa02/FiO2 ratio |
from patient arrival in the ED, to his leaving (from 1 hour to 24 hours) | |
Secondary | Overall survival at Day 28 | Patient status will be collected in the patient file. Every patient leaving the hospital before Day 28 will be considered alive at Day 28. | Day 1 to Day 28 (from patient arrival in the ED, to the 28th day after) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05095324 -
The Biomarker Prediction Model of Septic Risk in Infected Patients
|
||
Completed |
NCT02714595 -
Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
|
Phase 3 | |
Completed |
NCT03644030 -
Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
|
||
Completed |
NCT02867267 -
The Efficacy and Safety of Ta1 for Sepsis
|
Phase 3 | |
Completed |
NCT04804306 -
Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
|
||
Recruiting |
NCT05578196 -
Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections.
|
N/A | |
Terminated |
NCT04117568 -
The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
|
||
Completed |
NCT03550794 -
Thiamine as a Renal Protective Agent in Septic Shock
|
Phase 2 | |
Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
Completed |
NCT04227652 -
Control of Fever in Septic Patients
|
N/A | |
Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
Terminated |
NCT03335124 -
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
|
Phase 4 | |
Recruiting |
NCT04005001 -
Machine Learning Sepsis Alert Notification Using Clinical Data
|
Phase 2 | |
Completed |
NCT03258684 -
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock
|
N/A | |
Recruiting |
NCT05217836 -
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
|
||
Completed |
NCT05018546 -
Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery
|
N/A | |
Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
Not yet recruiting |
NCT06045130 -
PUFAs in Preterm Infants
|
||
Not yet recruiting |
NCT05361135 -
18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia
|
N/A | |
Not yet recruiting |
NCT05443854 -
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
|
Phase 3 |